Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Biotechnology
Cannabis
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare...
cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(58)
•••
zardoz00
X
Post by
zardoz00
on Aug 28, 2025 12:19pm
InMed presents INM-901 data at 2025 Alzheimer’s Association
https://ow.ly/MZxg50WNfpr
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 24, 2025 9:12am
Buy buddy buy because it's taking off this morning.
Otherwise FOMO
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 02, 2025 7:30am
Using technical analysis for this stock.
It is starting to climb upwards again today from its low prices per share and
(58)
•••
zardoz00
X
Post by
zardoz00
on Feb 03, 2025 2:24pm
INM-089 good progress on MD
https://www.inmedpharma.com/news_release/inmed-announces-inm-089-intravitreal-formulation-in-the-treatment-of-dry-age-related-macular-degeneration/
(243)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jan 21, 2025 10:19am
Buy buddy buy because it's taking off this morning.
So that you fellas should be getting on-board with this one
(58)
•••
zardoz00
X
Post by
zardoz00
on Jan 21, 2025 8:21am
Good results on long term tests INM-901
https://www.inmedpharma.com/investors/press-releases/
(58)
•••
zardoz00
X
Post by
zardoz00
on Oct 24, 2024 8:17am
INM to Participate in Fierce Biotech Webinar
InMed to Participate in Fierce Biotech Webinar on Neuroinflammation in Alzheimer's Disease
(58)
•••
zardoz00
X
Post by
zardoz00
on Oct 08, 2024 8:26am
INM-089 demonstrates positive effects on AMD
https://ow.ly/IHH050TBOYs
(58)
•••
zardoz00
X
Post by
zardoz00
on Sep 20, 2024 4:51pm
Delisting hearing on oct. 31th
INM could get an extra 180 days extension from September 16th 2024. https://www.inmedpharma.com/news_release/inmed-receives-nasdaq-delisting-notice-and-confirms-it-has-filed-an-appeal-and
...more
(58)
•••
zardoz00
X
Post by
zardoz00
on Sep 03, 2024 11:45am
New article sponsored by $INM
https://www.fiercebiotech.com/sponsored/evolving-alzheimers-disease-landscape
(58)
•••
zardoz00
X
Post by
zardoz00
on Aug 27, 2024 3:23pm
Progress with INM-089 for AMD
https://www.benzinga.com/partner/biotech/24/08/40573821/inmed-reports-encouraging-data-for-its-cannabinoid-inm-089-in-treating-dry-amd-an-ocular-disease-
(58)
•••
zardoz00
X
Post by
zardoz00
on Jul 30, 2024 6:39am
INM latest video on INM-901
https://youtu.be/CAvh2cNWpYA?si=fNbsv6GXbAfLjjhm
(58)
•••
zardoz00
X
Post by
zardoz00
on Apr 04, 2024 8:23am
Positive In Vivo Preclinical Alzheimer’s results
https://mailchi.mp/02da2462c4f8/inmeds-inm-901-demonstrates-favorable-pharmacological-and-behavioral-effects-in-in-vivo-preclinical-alzheimers-disease-studies?e=5815d309bc
(58)
•••
zardoz00
X
Post by
zardoz00
on Jan 25, 2024 9:16am
Good update on Inmed
https://wallstreetwaves.com/inmed-pharmaceuticals-has-multiple-milestones-coming-up-in-2024-with-a-focus-on-three-conditions-with-an-unmet-need/
(58)
•••
zardoz00
X
Post by
zardoz00
on Jul 27, 2023 5:10am
INM revenues have been exploding
https://mailchi.mp/550c403a5512/inmed-provides-update-on-baymedica-rare-cannabinoid-business?e=5815d309bc
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy